Other Income/Expenses (Net)

$55.71M

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$55.71Mperiod endingJun 30, 2026

LGND Quarterly Other Income/Expenses (Net) (-$1.30M → $55.71M)

Quarterly Other Income/Expenses (Net)

High-resolution chart · PNG

LGND other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Other Income/Expenses (Net) — Quarterly (USD)
Period ending	Other Income/Expenses (Net) (USD)
Jun 30, 2001	-52,000
Mar 31, 2001	-501,000
Dec 31, 2000	1,467,000
Sep 30, 2000	-1,914,000
Jun 30, 2000	-364,000
Mar 31, 2000	-681,000
Dec 31, 1999	-5,500,000
Sep 30, 1999	-165,000
Jun 30, 1999	0
Mar 31, 1999	0
Dec 31, 1998	-15,000,000
Sep 30, 1998	-28,000,000
Jun 30, 1998	0
Mar 31, 1998	0
Dec 31, 1997	-64,100,000
Sep 30, 1997	800,000
Jun 30, 1997	900,000
Mar 31, 1997	1,100,000
Dec 31, 1996	800,000
Sep 30, 1996	700,000
Jun 30, 1996	900,000
Mar 31, 1996	1,100,000
Dec 31, 1995	1,200,000
Sep 30, 1995	1,200,000
Jun 30, 1995	-5,400,000
Mar 31, 1995	-1,300,000
Dec 31, 1994	-1,400,000
Sep 30, 1994	-1,300,000
Jun 30, 1994	-1,400,000
Mar 31, 1994	-1,300,000